Back to top
Top

["Medication, Active": "Aromatase Inhibitors"]

Performance/Reporting Period
2020
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent aromatase inhibitor medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active or Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; both steroidal and non-steroidal inhibitors; both non-selective and selective inhibitors; aromatase inhibitors only.
Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; aromatase inhibitors in combination with other medications; selective inhibitors vorozole, formestane, and fadrozole.

Constrained to codes in the Medication, Active: Aromatase Inhibitors value set (2.16.840.1.113883.3.464.1003.196.12.1265)

QDM Datatype and Definition (QDM Version 5.4)

"Medication, Active"

Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set is being taken by the patient. Keep in mind that when this datatype is used with timing relationships, the criterion is looking for a medication being taken for the time frame indicated by the timing relationships.

A QDM Known Issue has been identified related to this datatype. To see this QDM known Issue, please click here.  

Timing: The Relevant Period addresses:

  • startTime - when the medication is first known to be used (generally the time of entry on the medication list),
  • stopTime - when the medication is discontinued (generally, the time discontinuation is recorded on the medication list)
Last Updated: Jul 08, 2021